Finnrick - Ensuring a Safer and More Transparent Supply Chain
PeptiAtlas

PeptiAtlas

Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP agonist) from PeptiAtlas between 17 Oct 2025 and 11 May 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
Tentative Rating
PeptiAtlas
Tirzepatide
Tested 5 Samples
Last test 11 May 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from PeptiAtlas

Samples are tested in commercial labs

Tests Count

5

Scores

AVG9.0MIN6.3MAX10.0

Last

11 May 2026

First

17 Oct 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
11 May 2026View10.030mg29.1mg-3.0%99.90%
not detected
March 02, 2026No Label / Silver Crimp / Pink CapLab EPublic
13 Dec 2025View6.330mg35.8mg+19.3%99.60%n/aNov 2 2025No Label / Silver Crimp / Pink CapLab GPublic
6 Dec 2025View10.050mg52.4mg+4.8%99.95%n/aOct 15 2025No Label / Silver Crimp / Green CapLab EPublic
5 Dec 2025View9.860mg59.7mg-0.5%99.80%n/aOct 15 2025No Label / Silver Crimp / Orange CapLab GPublic
17 Oct 2025View9.260mg64.3mg+7.2%99.85%n/aSept 4 2025No Label / Silver Crimp / Orange Cap Lab EPublic
Test my peptides for free